Founded in 1998, Gan & Lee Pharmaceuticals is a leading pharmaceutical company in China specializing in the development, production, and commercialization of recombinant insulin analogs and injection pens, and aiming to expand its reach globally. Headquartered in Beijing, Gan & Lee has an industrial park of about 200,000 square meters and nearly 2800 employees. With the aim of revitalizing China’s pharmaceutical industry and moving forward to advancing its goal of becoming a world-class pharmaceutical company, Gan & Lee will also take an active part in developing new chemical entities and biologics to treat various forms of cardiovascular disease, metabolic diseases, cancer, and other therapeutic areas. Please reach out to firstname.lastname@example.org for business inquiries.
Year Established: 1998
Total Number of Staff: more than 1000
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Production Capacity,Large Product Line,Reputation,Quality Service
Business Type: Manufacturer
R&D Capacity: OEM,Own Brand
Annual Turnover(USD) : More than 99,999,999
Main Sales Markets : Central/South America,Asia,Middle East